Product References
Oncogene-like addiction to aneuploidy in human cancers.
bioRxiv : the preprint server for biology
Girish V,Lakhani AA,Scaduto CM,Thompson SL,Brown LM,Hagenson RA,Sausville EL,Mendelson BE,Lukow DA,Yuan ML,Kandikuppa PK,Stevens EC,Lee SN,Salovska B,Li W,Smith JC,Taylor AM,Martienssen RA,Liu Y,Sun R,Sheltzer JM
Tue Jan 10 00:00:00 UTC 2023
Salvage of ribose from uridine or RNA supports glycolysis in nutrient-limited conditions.
Nature metabolism
Skinner OS,Blanco-Fernández J,Goodman RP,Kawakami A,Shen H,Kemény LV,Joesch-Cohen L,Rees MG,Roth JA,Fisher DE,Mootha VK,Jourdain AA
Mon May 01 00:00:00 UTC 2023
A reversible metabolic stress-sensitive regulation of CRMP2A orchestrates EMT/stemness and increases metastatic potential in cancer.
Cell reports
Boukouris AE,Zhang Y,Saleme B,Kinnaird A,Zhao YY,Liu Y,Zervopoulos SD,Das SK,Mittal RD,Haromy A,Lorenzana-Carrillo MA,Krysler AR,Cromwell CR,Hubbard BP,Sutendra G,Michelakis ED
Tue Mar 15 00:00:00 UTC 2022
A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline glioma.
Cancer cell
Pal S,Kaplan JP,Nguyen H,Stopka SA,Savani MR,Regan MS,Nguyen QD,Jones KL,Moreau LA,Peng J,Dipiazza MG,Perciaccante AJ,Zhu X,Hunsel BR,Liu KX,Alexandrescu S,Drissi R,Filbin MG,McBrayer SK,Agar NYR,Chowdhury D,Haas-Kogan DA
Mon Sep 12 00:00:00 UTC 2022
Adult T-cell leukemia-lymphoma acquires resistance to DNA demethylating agents through dysregulation of enzymes involved in pyrimidine metabolism.
International journal of cancer
Yoshida-Sakai N,Watanabe T,Yamamoto Y,Ureshino H,Kamachi K,Kurahashi Y,Fukuda-Kurahashi Y,Kimura S
Fri Apr 01 00:00:00 UTC 2022
Prognostic and predictive role of a metabolic rate-limiting enzyme signature in hepatocellular carcinoma.
Cell proliferation
Wang Z,Fu Y,Xia A,Chen C,Qu J,Xu G,Zou X,Wang Q,Wang S
Fri Oct 01 00:00:00 UTC 2021
Prognostic and predictive role of a metabolic rate-limiting enzyme signature in hepatocellular carcinoma.
Cell proliferation
Wang Z,Fu Y,Xia A,Chen C,Qu J,Xu G,Zou X,Wang Q,Wang S
Fri Oct 01 00:00:00 UTC 2021
Uridine-cytidine kinase 2 promotes metastasis of hepatocellular carcinoma cells via the Stat3 pathway.
Cancer management and research
Zhou Q,Jiang H,Zhang J,Yu W,Zhou Z,Huang P,Wang J,Xiao Z
Wed Mar 30 00:00:00 UTC 2022
Uridine-cytidine kinase 2 promotes metastasis of hepatocellular carcinoma cells via the Stat3 pathway.
Cancer management and research
Zhou Q,Jiang H,Zhang J,Yu W,Zhou Z,Huang P,Wang J,Xiao Z
Wed Mar 30 00:00:00 UTC 2022
Uridine-cytidine kinase 2 promotes metastasis of hepatocellular carcinoma cells via the Stat3 pathway.
Cancer management and research
Zhou Q,Jiang H,Zhang J,Yu W,Zhou Z,Huang P,Wang J,Xiao Z
Wed Mar 30 00:00:00 UTC 2022
Uridine-cytidine kinase 2 promotes metastasis of hepatocellular carcinoma cells via the Stat3 pathway.
Cancer management and research
Zhou Q,Jiang H,Zhang J,Yu W,Zhou Z,Huang P,Wang J,Xiao Z
Wed Mar 30 00:00:00 UTC 2022
Lack of cross-resistance to FF-10501, an inhibitor of inosine-5'-monophosphate dehydrogenase, in azacitidine-resistant cell lines selected from SKM-1 and MOLM-13 leukemia cell lines.
Pharmacology research & perspectives
Murase M,Iwamura H,Komatsu K,Saito M,Maekawa T,Nakamura T,Yokokawa T,Shimada Y
Mon Feb 01 00:00:00 UTC 2016
Lack of cross-resistance to FF-10501, an inhibitor of inosine-5'-monophosphate dehydrogenase, in azacitidine-resistant cell lines selected from SKM-1 and MOLM-13 leukemia cell lines.
Pharmacology research & perspectives
Murase M,Iwamura H,Komatsu K,Saito M,Maekawa T,Nakamura T,Yokokawa T,Shimada Y
Mon Feb 01 00:00:00 UTC 2016
Mechanisms of resistance to azacitidine in human leukemia cell lines.
Experimental hematology
Sripayap P,Nagai T,Uesawa M,Kobayashi H,Tsukahara T,Ohmine K,Muroi K,Ozawa K
Tue Apr 01 00:00:00 UTC 2014
Mechanisms of resistance to azacitidine in human leukemia cell lines.
Experimental hematology
Sripayap P,Nagai T,Uesawa M,Kobayashi H,Tsukahara T,Ohmine K,Muroi K,Ozawa K
Tue Apr 01 00:00:00 UTC 2014